TILT: Session 1 - Bind Research’s Technology

30 Sep 2026

Location: LBIC: Apex

TILT — lunchtime talks on cutting-edge research and biotech, organised by Laverock. Lunch and refreshments included.

The first session features Gabi Heller, CEO & CSO of Bind Research, speaking about their technology: how Bind trains AI to predict protein binding from sequence, unlocking drug discovery for "undruggable" targets such as cancer and neurodegeneration. 

Date: 30 September 2026
Time: 12:00 - 13:00
Location: LBIC: Apex
Event type: Internal Event

Food kindly provided by Thermo Fisher
Hosted by LBIC
Organised by Laverock Therapeutics